Ayça Altay Benetti achieved a significant milestone by completing her PhD in pharmacokinetics and
biopharmaceutics in 2021 from the University of Parma, Italy. She founded PronioBioTech, a startup in
transdermal drug delivery for arthritis treatment, thanks to the NUS GRIP 10 innovation program. Through her
strategic leadership and vision, the company is advancing innovation in the field. She has deep understanding of
the pharmaceutical industry, drug delivery technologies, and regulatory requirements has propelled her
company’s success.
She has presented papers at over ten national and international conferences and has 17 publications in reputable
journals. Currently, Ayça is a research fellow at the National University of Singapore, continuing her pioneering
work. Her journey, from an ambitious student in Parma to an influential entrepreneur and researcher in Singapore,
exemplifies her tenacity, expertise, and visionary approach. Ayça Altay Benetti continues to inspire and lead
advancements in pharmacokinetics and biopharmaceutics.
Ayca Altay Benetti
CEO and Startup founder (PronioBioTech) / Research Fellow (NUS)
PronioBioTech